RecruitingNot ApplicableNCT07665372

Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)

HOPE in Action Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes

Sponsor

Johns Hopkins University

Enrollment

80 participants

Start Date

Nov 1, 2026

Study Type

INTERVENTIONAL

Conditions

HIV

Summary

This research is being done to better understand opportunistic infections and cancer in transplant recipients with HIV who receive livers from a donor with HIV compared to livers from donors without HIV.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying HIV D+/R+ and HIV D-/R+ for people with hiv. The study is currently recruiting participants at 19 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERHIV D+/R+

Receipt of liver transplant from a deceased donor with HIV

OTHERHIV D-/R+

Receipt of liver transplant from a deceased donor without HIV

Locations(19)

Mayo Clinic, Arizona

Phoenix, Arizona, United States

Cedars-Sinai Medical Center

Los Angeles, California, United States

University of California, San Francisco

San Francisco, California, United States

University of Colorado Anschutz

Aurora, Colorado, United States

Mayo Clinic, Florida

Jacksonville, Florida, United States

University of Miami, Miami Transplant Institute

Miami, Florida, United States

Emory University

Atlanta, Georgia, United States

Northwestern University

Chicago, Illinois, United States

Ochsner Clinic Foundation

Jefferson, Louisiana, United States

Johns Hopkins University

Baltimore, Maryland, United States

Massachusetts General Hospital

Boston, Massachusetts, United States

New York University School of Medicine

New York, New York, United States

Icahn School of Medicine at Mount Sinai

New York, New York, United States

Weill Cornell Medical College

New York, New York, United States

University of Cincinnati

Cincinnati, Ohio, United States

Ohio State University Medical Center

Columbus, Ohio, United States

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

University of Texas Southwestern Medical Center

Dallas, Texas, United States

Houston Methodist Research Institute

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07665372

Related Trials

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

NCT054704911 location

The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control Through PrEP (IN-STEP) Study

NCT067432041 location

Accurate Staging of Immuno-virological Dynamics During Acute HIV Infection

NCT034497061 location

Prison-Based HIV Partner Notification

NCT07103928

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

NCT000065181 location